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Abstract: Iodine excess may impair thyroid function and trigger adverse health consequences for
children. This study aims to describe iodine status among breastfed infants with high iodine exposure
in the Saharawi refugee camps Algeria, and further assess thyroid function and iodine status among
the children three years later. In 2010, a cross-sectional study among 111 breastfed children aged
0–6 months was performed (baseline study). In 2013, a second cross-sectional study (follow-up study)
was conducted among 289 children; 213 newly selected and 76 children retrieved from baseline.
Urinary iodine concentration (UIC) and breast milk iodine concentration (BMIC) were measured
at baseline. UIC, thyroid hormones and serum thyroglobulin (Tg) were measured at follow-up.
At baseline and follow-up, 88% and 72% had excessive iodine intakes (UIC ě 300 µg/L), respectively.
At follow-up, 24% had a thyroid hormone disturbance and/or elevated serum Tg, including 9% with
subclinical hypothyroidism (SCH), 4% with elevated fT3 and 14% with elevated Tg. Children with
SCH had poorer linear growth and were more likely to be underweight than the children without
SCH. Excessive iodine intakes and thyroid disturbances were common among children below four
years of age in our study. Further, SCH seemed to be associated with poor growth and weight.
Keywords: iodine excess; urinary iodine concentration; breast milk iodine; iodine intake; thyroid
function tests; hypothyroidism; thyroglobulin
1. Introduction
Iodine deficiency remains a global health problem, but there has been great progress in eliminating
iodine deficiency disorders over the last few decades [1,2]. Based on median urinary iodine
concentration (UIC) among school-aged children, the number of countries with adequate iodine
intake has increased from 67 to 112 over the past 10 years. In addition, iodine excess has become
more prevalent over the past decade mainly because of salt iodization, and, in 2013, 10 countries
were classified with excessive iodine intakes (median UIC ě 300 µg/L) [3]. Fetuses and newborns
are high-risk groups for excessive iodine exposure, since their thyroid gland is immature and has less
adaptive abilities for high iodine doses than for adults. This is probably because the thyroids of fetuses
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and newborns are unable to escape from the acute Wolff-Chaikoff effect [4–7]. In addition, infants are
particularly vulnerable when it comes to iodine excess, since thyroid hormone disturbances may affect
their growth and developmental skills [8,9]. For breastfed infants, the mother’s iodine intake is of
importance, since iodine is excreted through breastmilk [10–12].
Although chronical iodine excess in pediatric populations is an area of limited research, studies
have shown both increased thyroid volume [13,14] and thyroid disturbances [15,16] in children
exposed to excessive iodine. However, there is limited knowledge concerning the longitudinal effects
of chronically excessive iodine exposure in children, particularly at the preschool age.
In the southwest of the Algerian desert near the city of Tindouf, approximately 165,000 refugees
are living in the Saharawi refugee camps. People living in these camps are exposed to high iodine from
groundwater [17], which is probably responsible for endemic goiter among women and children [18,19]
and a high prevalence of thyroid dysfunction among women [20,21]. We conducted two studies in
the refugee camps to assess the consequences of chronically high iodine exposure in lactating women
and their children: a cross-sectional iodine study in 2010 (baseline study) and a second study in 2013
(follow-up study) [20,21]. The main objective of the present paper is to describe breast milk iodine
concentration (BMIC) and the iodine status among breastfed children aged 0–6 months living in an area
of high iodine exposure (at baseline) and to describe serum concentration of thyroid hormones, thyroid
function, and iodine status among the children at three years of age (at follow-up). Our hypotheses
were as follows: the children have (a) excess iodine intake in early infancy (baseline) and early
childhood (follow-up); and (b) thyroid hormone disturbances and elevated serum thyroglobulin (Tg)
during early childhood (follow-up).
2. Materials and Methods
2.1. Subjects
The sample size calculations and selection procedures were previously described for the baseline
study [21]. Three years later, in 2013, the follow-up study was performed. Among the 111 children
from baseline, 76 were included at follow-up. Furthermore, a new sample of randomly selected
children from lists made from a census of the Saharawi health authorities (n = 213) born between 2010
and 2011 were included to increase the sample size to 289. The sampling procedure and exclusions are
described in Figure 1.
trie ts , ,   f  
and has less adaptive abilities for high iodine doses than for adults. This is probably because the 
thyroids of fetuses and newborns are unable to escape from the acute Wolff-Chaikoff effect [4–7]. In 
addition, infants are particularly vulnerable when it comes to iodine excess, since thyroid hormone 
disturbances may affect their growth and developmental skills [8,9]. For breastfed infants, the 
mother’s iodine intake is of importance, since iodine is excreted through breastmilk [10–12].  
Although chronical iodine excess in pediatric populations is an area of limited research, studies 
have shown both increased thyroid volume [13,14] and thyroid disturbances [15,16] in children 
exposed to excessive iodine. However, there is limited knowledge concerning the longitudinal 
effects of chronically excessive iodine exposure in children, particularly at the preschool age.  
In the southwest of the Algerian desert near the city of Tindouf, approximately 165,000 refugees 
are living in the Saharawi refugee camps. People living in these camps are exposed to high iodine 
from groundwater [17], which is probably responsible for endemic goiter among women and 
children [18,19] and a high prevalence of thyroid dysfunction among women [20,21]. We conducted 
two studies in the refugee camps to assess the consequences of chronically high iodine exposure in 
lactating women and their children: a cross-sectional iodine study in 2010 (baseline study) and a 
second study in 2013 (follow-up study) [20,21]. The main objective of the present paper is to describe 
breast milk iodine concentration (BMIC) and the iodine status among breastfed children aged 0–6 
months living in an area of high iodine exposure (at baseline) and to describe serum concentration of 
thyroid hormones, thyroid function, and iodine status among the children at three years of age (at 
follow-up). Our hypotheses were as follows: the children have (a) excess iodine intake in early 
infancy (baseline) and early childhood (follow-up); and (b) thyroid hormone disturbances and 
elevated serum thyroglobulin (Tg) during early childhood (follow-up).  
2. Materials and Methods  
2.1. Subjects 
The sample size calculations and selection procedures were previously described for the 
baseline study [21]. Three years later, in 2013, the follow-up study was performed. Among the 111 
children from baseline, 76 were included at follow-up. Furthermore, a new sample of randomly 
selected children from lists made from a census of the Saharawi health authorities (n = 213) born 
between 2010 and 2011 were included to increase the sample size to 289. The sampling procedure 
and exclusions are described in Figure 1.  
 
Figure 1. Flowchart for selection of Saharawi children at baseline (2010) and follow-up (2013). * low 
age, high age, deaf and mute.  
 
Figure 1. Flowchart for selection of Saharawi children at baseline (2010) and follow-up (2013). * low
age, high age, deaf and mute.
Nutrients 2016, 8, 398 3 of 12
2.2. Urine and Water Samples
Spot urine samples were collected from all participants at baseline and follow-up. Uri Max
urine bags (Servoprax GmbH, Wesel, Germany) were used to collect the children’s urine at baseline.
A Vacuette Urine System with transfer device (Vacuette, Krensmünster, Austria) was used for sampling
and storage. All samples were stored at ´20 ˝C until analyzed. Analyses of iodine in urine and water
were performed by a modified Sandell-Kolthoff reaction [22,23]. Acid digestion by an oxidative reagent,
ammonic persulfate, was used to eliminate interfering substances (100 ˝C for 60 min). Arsenic acid
was the reducer reagent in the analyses, and the results were read spectrometrically on microtiter
plates. Analyses were performed at the Nutritional Intervention Research Unit in Cape Town, South
Africa at baseline and at La Paz University Hospital Foundation for Biomedical Research in Madrid,
Spain at follow-up. The World Health Organization (WHO) epidemiological criteria for assessing
iodine nutrition based on the median UIC were used to describe the urine data [1].
2.3. Breast Milk Samples
Data on BMIC have previously been published with descriptions of the sampling methods and
analyses [21]. We estimated the daily iodine intake for children based on BMIC from our study and
mean breastmilk intake calculated by the WHO [24] using breastmilk intake in liter * BMIC in µg/L.
We used intake data for predominantly breastfed children from developing countries, since these were
mostly in accordance with our population.
2.4. Anthropometric Measures
Body weight was measured using a UNICEF digital platform scale (SECA 890, Hamburg,
Germany). At baseline, the infants’ weight was measured when being held by their mothers after
resetting the weight scale. Height/length was measured to the nearest 0.1 cm using a portable
UNICEF length board. The gender-specific Z-scores height-for-age (HAZ), weight-for-age (WAZ),
and weight-for-height (WHZ) were calculated using the WHO macro for SPSS [25,26]. A child was
categorized as undernourished if HAZ, WAZ, or WHZ also referred to as stunting, underweight,
and wasting was <´2 [26]. Both at baseline and follow-up, the mothers of the children answered a
pre-coded questionnaire concerning the child’s birth date, gender and household size.
2.5. Serum Samples and Thyroid Hormones
At follow-up, blood samples were drawn from all participants using plastic clot activator gel tubes
(BD Vacutainer SST II, Oxford, UK). Samples were kept at 5 ˝C until centrifuged and separated from
the blood pellet within 2 hours after extraction. Serum samples were stored in transfer tubes and kept
frozen at ´20 ˝C until analyzed. Serum thyrotropin (TSH), free thyroxine (fT4), free triiodothyronine
(fT3), Tg, and antibodies to thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) were analyzed by
electrochemiluminescence immunoassay on Module E170 by Roche Diagnostics at La Paz University
Hospital Foundation for Biomedical Research in City, Spain. To classify thyroid hormone disturbances
in children, the age-dependent reference range from the manufacturer was used [27]. The reference
ranges were 0.70–6.0 mIU/L for TSH, 12.3–22.8 pmol/L for fT4, and 3.7–8.5 pmol/L for fT3. For the
thyroid antibodies TgAb and TPOAb, reference values of <38 kIU/L and <13 kIU/L were used,
respectively. For Tg, <67 µg/L was used as a reference value. Subclinical hypothyroidism was defined
as TSH above the reference and fT4 within the reference. Overt hypothyroidism was defined as TSH
above the reference with fT4 below the reference or highly elevated TSH (>10 mIU/L) and fT4 in the
lower quartile. Subclinical hyperthyroidism was defined as TSH below the reference and both fT3 and
fT4 within the reference. Overt hyperthyroidism was defined with TSH below the reference and fT3 or
fT4 above the reference ranges.
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2.6. Ethical Considerations
Ethical approval for the baseline and follow-up studies (ref. 2010/2513 and 2013/192) was
provided by the Regional Committees for Medical and Health Research Ethics in Norway and the
Saharawi Ministry of Public Health. Written informed consent was given by the mothers on behalf of
the children.
2.7. Statistics
Data were analyzed using IBM SPSS version 22 (IBM Corp., Armonk, NY, USA).
Normally distributed data were presented as mean (SD), while skewed data was presented with
median and 25–75th percentiles (p25–p75) or range.
In linear regression analyses, we measured the associations between different baseline and
follow-up variables. We used a purposeful manual forward selection procedure to identify the predictor
variables (Table 1). The dependent variables UIC baseline, UIC follow-up, TSH, Tg, and fT3 were log(2)
transformed for better fit to the model. The predictor variable Tg was log(2) transformed in the fT4
model due to a non-linear relation. Outliers resulting in standard residuals outside ˘3 were removed
from the models. The independent variables were tested for association one by one. Only variables
with a significant association (p < 0.05) were retained in the multiple models. The variables that
remained significant in the multiple models are presented in the results (Table 5). All originally
selected variables were re-included one by one in the multiple model to check for missed associations.
Results regarding TSH, fT3, and fT4 are presented in Table 5, while results regarding UIC from baseline
and follow-up, and Tg is presented in the text.
Table 1. Overview of predictor variables used in linear regression models for the dependent variables
UIC baseline, UIC follow-up, TSH, Tg, fT3 and fT4.
Dependent Variables Predictor Variables
Baseline Follow-Up
UIC baseline b HAZ, WAZ, WHZ, age, gender, BMIC -
UIC follow-up b HAZ, WAZ, WHZ, breastfeeding status, age, gender
TSH follow-up a fT3, fT4, UIC, breastfeeding status, age, gender
Tg b fT3, fT4, UIC, breastfeeding status, age, gender
fT4 a UIC, Tg, breastfeeding status, age, gender
fT3 a UIC, Tg, breastfeeding status, age, gender
a Results shown in Table 5 in the results; b Results presented in the text only. Height/length-for-age (HAZ),
Weight-for-age (WAZ), Weight-for-height (WHZ).
We also examined the association between subclinical hypothyroidism and HAZ, WAZ, and WHZ
using multiple logistic regression models. The models were adjusted for breastfeeding status, and the
results are shown in Table 6.
3. Results
Background characteristics and iodine status from the baseline and follow-up studies are described
in Table 2. The median age of the children was 3.1 months at baseline, while it was 31.4 months at
follow-up. At baseline, 16.5%, 13.8%, and 8.2% were underweight, stunted, and wasted, respectively.
At follow-up, 11.8% were underweight, 33.2% were stunted, and 3.8% were wasted. All children
were breastfed at baseline, and 13.8% were still breastfed at follow-up. The median (p25–p75) UIC
were 722 (393–1133) µg/L and 458 (275–1026) µg/L at baseline and follow-up, respectively (p = 0.003).
The median (p25–p75) BMIC at baseline was 479 (330–702) µg/L.
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Table 2. Background characteristics and iodine status among the children at baseline and follow-up a.
Characteristics Baseline (n = 111) Follow-up (n = 289)
Age, months 3.1 (2.2–4.8) 31.4 (25.3–35.1)
Male 40 [36.0] 138 [47.8]
Female 71 [64.0] 151 [52.2]
Household size, number 5.1 ˘ 1.9 5.3 ˘ 1.8
Breast-fed 111 [100.0] 40 [13.8]
Weight-for-age, z-score ´0.8 ˘ 1.3 ´1.0 ˘ 0.9
<´2 (underweight) 18 [16.5] 34 [11.8]
Length/height-for-age, z-score ´0.6 ˘ 1.2 ´1.6 ˘ 1.1
<´2 (stunted) 15 [13.8] 96 [33.2]
Weight-for-length/height, z-score ´0.3 ˘ 1.2 ´0.1 ˘ 1.0
<´2 (wasted) 9 [8.2] 11 [3.8]
Iodine status
UIC, µg/L 722 (393´1133) 458 (275´1026) *
BMIC, µg/L b 479 (330´702)
a Values are presented as mean ˘ SD, median (p25–p75), and n [%]. Two missing from anthropometric data
baseline, one from follow-up. One missing UIC follow-up. One missing age child baseline; b Data for BMIC is
previously published by Aakre et al. [20,21]. Only measured at baseline. * UIC baseline and follow-up were
statistically significant different (p = 0.003) tested with Mann–Whitney U.
Figure 2 shows the percentage distributions of children in different categories of iodine nutrition
based on the UIC from baseline and follow-up. At baseline, none had a UIC < 100 µg/L, 11.7% had a
UIC of 100–299 µg/L, and 88.3% had a UIC ě 300 µg/L. At follow-up, 2.4% had a UIC < 100 µg/L,
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Table  3  shows  the  daily  estimated  iodine  intake  among  breastfed  children  from  baseline. 
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Figure 2. Percentage distribution of children’s UIC at follow-up (n = 289) and UIC at baseline (n = 111)
according to different categories of iodine status.
Table 3 shows the daily estimated iodine intake among breastfed children from baseline.
Estimated iodine intake from breastmilk increases up to five months of age. Across age groups,
the average estimated iodine intake from breast milk is 299 (206–438) µg/day for predominantly
breastfed children.
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Table 3. Estimated iodine intake in age groups 1–6 months based on median (p25–p75) BMIC.
Age in Months Estimated Breast MilkIntake (g/Day) (3)
Estimated Iodine Intake from
Breast Milk (µg/Day) a
1 568 272 (187–399)
2 636 305 (210–446)
3 574 275 (189–403)
4 643 308 (212–451)
5 714 342 (236–501)
6 611 293 (202–429)
Mean 624 299 (206–438)
a Calculated by breastmilk intake (3) in g/day*mean (p25–p75) BMIC in µg/g for our study.
Table 4 describes the serum concentrations of thyroid hormones and Tg, as well as the
biochemically assessed thyroid function tests among the children. The median/mean values of
thyroid hormones and Tg are within the middle of the reference ranges, except for fT3, which is found
in the upper area. No children were found to be TgAb or TPOAb positive (data not shown for thyroid
antibodies). We found that 9.3% had subclinical hypothyroidism, and among these, 37.0% had elevated
Tg and 3.7% had elevated fT3. None had overt hypothyroidism; however, three children had TSH
between 10 and 15 mIU/L with fT4 values above the lower quartile. One child (0.4%) had subclinical
hyperthyroidism and one (0.4%) had overt hyperthyroidism. We also found three children (1%) with
marginally low fT4 and eight children (2.8%) with elevated fT3 together with TSH within the reference
ranges. Two of the children with fT3 and fT4 outside the reference ranges had elevated Tg. In total,
thyroid function tests were abnormal among 13.8% of the children. We found that 9.7% had elevated
Tg without any thyroid disturbances. In total, 13.2% had elevated Tg, counting those with and without
abnormal thyroid function tests. The total prevalence with abnormal thyroid function tests and/or
elevated Tg was 23.5%.
Table 4. Thyroid hormone status and thyroid function tests among children at follow-up a.
Thyroid Hormones and Thyroid Function Tests Children (n = 289) Reference Range
TSH, mIU/L 3.1 (0.2–15.3) 0.70–6.0
fT4, pmol/L 16.3 (11.2–21.8) 12.3–22.8
fT3, pmol/L 6.9 (3.9–17.2) 3.7–8.5
Tg, µg/L 38.4 (10.7–158.0) <67
Subclinical hypothyroidism b 27 [9.3]
Subclinical hyperthyroidism 1 [0.4]
Overt hyperthyroidism 1 [0.4]
fT4 low <12 pmol/L, normal TSH c 3 [1.0]
fT3 elevated >8.5 pmol/L, normal TSH d 8 [2.8]
Tg elevated >67 µg/L, normal thyroid tests 28 [9.7]
Total thyroid disturbance and/or elevated Tg 68 [23.5]
a Data are presented as median/mean (min-max) and n [%]; b Among children with subclinical hypothyroidism
there were 10 [37%] with elevated Tg, one had elevated fT3; c Among low fT4, one had elevated Tg; d Among
children with elevated fT3, one had elevated Tg.
Predictors for TSH, fT4, and fT3 at follow-up are shown in Table 5. In the multiple model, Tg
and fT3 were positively associated with TSH, explaining 11.3% of the variance in TSH. There were
no significant associations between TSH and UIC, fT4, breastfeeding status, age, or gender. fT4 was
positively associated with Tg, explaining 1.4% of the variance in fT4. No significant associations were
found between fT4 and UIC, breastfeeding status, age, or gender. For fT3, a negative association with
UIC was found, where UIC explained 6.7% of the variance in fT3. No significant associations were
found between fT3 and Tg, breastfeeding status, age or gender. We also explored predictors for Tg,
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UIC baseline, and UIC follow-up (data only presented in the text). Tg was associated with TSH as
the only variable, explaining 11.6% of the variance. Iodine status, expressed as UIC, was positively
associated with BMIC as the only variable at both follow-up and baseline. At baseline, BMIC explained
23.1% of the variance in UIC, while at follow-up, gender was the only significant predictor of UIC,
where UIC seemed to be higher among male children than female, explaining 2.9% of the variance.
Table 5. Predictors for TSH, fT4 and fT3 (n = 289).
Dependent
Variables a Predictor Variables
Unadjusted/Adjusted




TSH Tg mg/L 6.2 (3.9´8.5) <0.001 0.297
fT3 pmol/L 0.09 (0.02´0.15) 0.011 0.143 0.113
fT4 b Tg c 0.3 (0.01, 0.5) 0.043 0.120 0.014
fT3 UIC follow-up mg/L ´0.04 (´0.06, ´0.02) <0.001 ´0.260 0.067
a The dependent variables TSH and fT3 were log (2) transformed, n = 286 for TSH, n = 284 for fT4 and n = 283
for fT3; b Ft4 is given in pmol/L; c Tg as a predictor variable was log(2) transformed due to a non-linear relation;
d TSH model adjusted for Tg and fT3. In fT4 and fT3 models, unadjusted coefficients are shown.
Nutritional status according to subclinical hypothyroidism is presented in Table 6. Children with
subclinical hypothyroidism had significantly lower HAZ (p = 0.004) and WAZ (p = 0.012) compared to
those without hypothyroidism; this result was the same after adjusting for breastfeeding status.




Yes (n = 27) No (n = 260) b
Length/height-for-age, z-score ´2.2 ˘ 1.0 ´1.6 ˘ 1.1 0.004
Weight-for-age, z-score ´1.4 ˘ 0.8 ´0.9 ˘ 1.0 0.012
Weight-for-length/height, z-score ´0.3 ˘ 0.8 ´0.1 ˘ 1.0 0.349
a Values are presented as mean ˘ SD. Differences are tested by independent sample t-tests. Associations
between HAZ, WAZ and TSH levels remained significant when adjusted for breastfeeding status in multiple
regression analyses; b Two children with hyperthyroidism were excluded from the analyses.
4. Discussion
In this study, we found a high prevalence of thyroid disturbances among young children who
reside in an area of chronically high iodine exposure. High iodine intakes were identified both at
baseline and follow-up.
As illustrated in Figure 2, 88% and 72% had UIC ě 300 µg/L at baseline and follow-up,
respectively. UIC ě 300 µg/L is used as a cut-off by the WHO for indicating iodine excess with
a risk of adverse health consequences for school-aged children [1]. However, for younger children,
a cut-off indicating excessive iodine intake based on the UIC has not yet been developed. UIC were
assessed with spot urine samples, which is the recommended method for assessing iodine status in
population groups by the WHO [1], and also recently reviewed as a reliable biomarker for groups [28].
Even so, spot sampling has weaknesses because it is affected by day-to-day hydration level, and there
may be wide daily variation in UIC [29–31], meaning that an individual showing UIC < 100 µg/L
does not necessarily need to be iodine deficient. In this study, all of the children were breastfed
at baseline and the mean estimated iodine intake from breast milk was 299 µg/day. This is over
three times higher than the recommended daily intake from the WHO of 90 µg/day for children
under two years of age [1], and one and a half times as high as the US Institute of Medicine and the
European Scientific Committee on Food’s tolerable upper intake level (UL) of 200 µg/day for children
of 1–3 years [32,33]. This finding is in accordance with the UIC levels, indicating excessive iodine
intakes among the children.
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Median UIC was significantly higher at baseline than at follow-up. The iodine content in the
urine samples was analyzed in two different laboratories, which may explain some of the differences.
Both laboratories used a modified Sandell–Kolthoff reaction for iodine measurement; however, we
have no data for comparison analysis. All children from baseline were breastfed, while only a small
proportion were breastfed at follow-up, since these children were older. The median BMIC was
extremely high (479 µg/L), and since the children were receiving more breastmilk at baseline than at
follow-up, the difference in UIC can likely be explained by this.
In the final regression model, BMIC was a predictor of the children’s UIC at baseline. This finding
is in concordance with other studies [34–36]. Even though the explained variance was small (2.9%),
gender was the only predictor of UIC follow-up, whereas male children seemed to have higher
UIC than female children, at follow-up. This may be due to different dietary habits between male
and female children. However, we do not see gender differences in regards to any of the thyroid
parameters. We also explored whether TSH could be associated with iodine status, and TSH was tested
for associations with UIC follow-up, UIC baseline, and BMIC at baseline. No significant associations
were found for any of the mentioned variables. This may be due to the very large intra-individual
variability of the UIC and BMIC measurements. Similarly, no association was found between UIC and
TSH in two Iranian studies where urinary iodine was not associated with thyroid function or TSH
in newborns in an iodine-sufficient area [35,37], or in a recent study by Nepal et al., where TSH was
associated to neither UIC nor serum Tg in children living under chronic iodine excess [15].
Even though neither UIC nor BMIC predicted TSH in our study, others have reported an
association between UIC and TSH in children. In a Chinese study of children living under
long-term iodine excess, subclinical hypothyroidism was significantly higher among children with
UIC > 600 µg/L than among children with a lower UIC [16]. A Korean study among preterm infants
found that urinary iodine was significantly higher among children with subclinical hypothyroidism
after three weeks, but not after six weeks of life [11]. In our study, serum Tg was positively associated
with TSH. Tg has been found to be a sensitive marker of iodine nutrition, also in areas of iodine
excess [1,38]. At follow-up, 13.8% of the children were still breastfed. Breastfeeding status was not
significantly associated with UIC, TSH, fT4, fT3, or Tg at follow-up.
Evaluating the thyroid hormone status in Table 4, we see that 9.3% had subclinical hypothyroidism.
Studies on thyroid function in healthy populations of infants are limited [39,40]. The most cited
study on thyroid function in a pediatric population was carried out among US adolescents where
1.7% had subclinical hypothyroidism [41]. A large study among schoolchildren conducted in India
after salt iodization revealed prevalences of subclinical and overt hypothyroidism of 6.1% and 0.4%,
respectively [42]. However, the results of these two studies may not be comparable to our data, since
it is known that thyroid disturbances may increase when improving iodine status after long-term
deficiency [43], and because higher age groups were studied than in our material. In a retrospective
analysis of TSH from a large database in Israel, elevated TSH was found in 2.9% and highly elevated
TSH (>10 mlU/L) in 0.4% of children between six months and 16 years of age [44]. Compared to this
study, our prevalence of 9.3% may be considered high, especially taking into account the vulnerable
age group of our population group. Studies from other child populations with long-term iodine
excess have found similar results to ours; Nepal et al. reported a prevalence of 7.4% with subclinical
hypothyroidism and 15.8% with elevated Tg (using the international Tg reference) among Nepalese
infants aged 6–24 months [15]. Moreover, Sang et al. found about 5% of Chinese children of 7–13 years
had subclinical hypothyroidism [16].
We do not know the optimal reference ranges of thyroid hormones and antibodies in our
population. The reference used is of great significance of the reported prevalence of thyroid hormone
disturbances. In a population of healthy children aged 2–7 years, the range of TSH was found
to be 0.10–5.9 mIU/L, measured by AutoDelfia [45], which corresponds well to the references we
have applied.
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Ten children (3.5%) had elevated fT3; of which eight had TSH within the reference, one had low
TSH, and one had high TSH. All children had normal fT4 values. To the best of our knowledge, the
pattern of elevated fT3 in relation to iodine excess has not been described previously. Furthermore,
our data suggested a positive association between TSH and fT3 in the multiple regression analyses.
This same association was found in a large pediatric population where normal or slightly above normal
TSH levels correlated positively with fT3 [46] and not with fT4 among children of normal weight.
The authors of the paper stated that the mechanism by which TSH levels are associated with higher
fT3 levels and not higher fT4 levels remains unknown.
Studies examining possible outcomes of untreated subclinical hypothyroidism in children remain
scarce [39], and there are uncertainties related to the effect of treating the condition among children [47].
Many studies have not seen any clinical manifestations of subclinical hypothyroidism. In our study,
children with subclinical hypothyroidism also had statistically significant lower length/height-for-age
and weight-for-age than children without, which may suggest a potential link between subclinical
hypothyroidism and linear growth and weight faltering, though the observational design of our study
limits our ability to infer causality. Improved growth after treatment of subclinical hypothyroidism
has been shown in some studies [48,49], and the growth of the children in our study should therefore
be monitored.
Strengths and Limitations
In this study, we have explored an under-reported phenomenon; the occurrence of thyroid
dysfunction in a population with excessive iodine exposure. In addition, information on thyroglobulin
levels and fT3 levels in children with chronically high iodine exposure is a contribution to the scientific
literature on the subject, as there are limited normative data on these analytes. However, our ability
to explore associations with iodine status and thyroid function was limited due to limitations of the
available biomarkers. Data on thyroid parameters was not collected from baseline because of the very
young age of the children.
5. Conclusions
In conclusion, we found consistently high iodine intakes among children aged 0–6 months
at baseline and three years later at follow-up. The high iodine exposure may have affected thyroid
hormone status, possibly resulting in elevated fT3 in some of the children, as well as a higher proportion
with elevated TSH and Tg than expected. Iodine excess is an environmental risk factor for the
development of thyroid function disorders, especially in susceptible individuals, such as infants,
which, in turn, represent a risk factor for developmental delays and poor ponderal and linear growth.
Therefore, the thyroid function should be carefully monitored in areas with environmental risk of
high iodine exposure, and the need for establishing upper reference levels for iodine nutrition among
young children must be addressed. Furthermore, we would recommend purification of ground water
in the Saharawi refugee camps, as a strategy to reduce the iodine exposure in the population.
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